Palvella Therapeutics (PVLA) Assets Average (2016 - 2024)
Historic Assets Average for Palvella Therapeutics (PVLA) over the last 12 years, with Q3 2024 value amounting to $22.8 million.
- Palvella Therapeutics' Assets Average fell 6898.11% to $22.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $22.8 million, marking a year-over-year decrease of 6898.11%. This contributed to the annual value of $51.5 million for FY2023, which is 5862.76% down from last year.
- According to the latest figures from Q3 2024, Palvella Therapeutics' Assets Average is $22.8 million, which was down 6898.11% from $27.3 million recorded in Q2 2024.
- Over the past 5 years, Palvella Therapeutics' Assets Average peaked at $159.6 million during Q3 2021, and registered a low of $18.5 million during Q1 2024.
- Over the past 5 years, Palvella Therapeutics' median Assets Average value was $110.4 million (recorded in 2020), while the average stood at $98.4 million.
- Per our database at Business Quant, Palvella Therapeutics' Assets Average surged by 4394.88% in 2021 and then crashed by 7915.87% in 2024.
- Palvella Therapeutics' Assets Average (Quarter) stood at $110.4 million in 2020, then skyrocketed by 43.95% to $158.9 million in 2021, then tumbled by 38.74% to $97.3 million in 2022, then crashed by 65.62% to $33.5 million in 2023, then plummeted by 31.9% to $22.8 million in 2024.
- Its last three reported values are $22.8 million in Q3 2024, $27.3 million for Q2 2024, and $18.5 million during Q1 2024.